Testing a new psoriasis skin cream in adults
Part of Immune system & allergy, Skin clinical trials.
This study tests whether a new ointment called RSS0393 can safely and effectively treat plaque psoriasis (a common skin condition causing red, scaly patches). You would apply it to affected skin areas and be compared to people using a placebo (inactive cream) to see if the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with plaque psoriasis for at least 6 months
- Your psoriasis covers between 2% and 20% of your body (roughly the size of your hand to a larger area)
- You have not used psoriasis treatments (topical creams within 2 weeks, pills or light therapy within 4 weeks, or biologic injections within a longer period) before starting the study
- Your blood tests and heart rhythm are normal, and you do not have hepatitis B, HIV, syphilis, or hepatitis C
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ointment called RSS0393 in children and teenagers aged 6 to 17 who have plaque psoriasis. The goal is to see if the ointment is safe and how it works in the body. This may offer a new treatment option for those whose psoriasis has not cleared with other treatments.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This study tests a new medicine called SHR-1314 for children aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if it safely reduces skin redness, scaling, and thickness.
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
This trial tests an ointment called RSS0393 for people with plaque psoriasis. It aims to see if the ointment is safe and effective in reducing psoriasis symptoms.
This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.
Hear when a new Plaque Psoriasis Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.